Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first

被引:113
作者
Bollet, Marc A.
Sigal-Zafrani, Brigitte
Mazeau, Vaerie
Savignoni, Atexia
de la Rochefordiere, Anne
Vincent-Salomon, Anne
Salmon, Remy
Campana, Francois
Kirova, Youlia M.
Dendale, Remi
Fourquet, Alain
机构
[1] Inst Curie, Dept Radiat Oncol, F-75005 Paris, France
[2] Inst Curie, Dept Pathol, F-75005 Paris, France
[3] Inst Curie, Dept Surg, F-75005 Paris, France
[4] Inst Curie, Dept Biostat, F-75005 Paris, France
关键词
breast cancer; breast-conserving treatment; young age; loco-regional control; prognostic factor;
D O I
10.1016/j.radonc.2007.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To ascertain the loco-regional recurrence (LRR) rate and its major prognostic factors in patients younger than 40 and to determine the influence of age on the features of breast cancer and its treatment in two age groups: <= 35 years and [36-39] years. Methods and materials: Between 1985 and 1995, 209 premenopausal women, younger than 40, were treated for early breast cancers with primary breast conserving surgery followed by radiotherapy +/- chemotherapy. Median age was 37 years with 66 patients (32%) <= 35 years and 143 older (68%). Median follow-up was 12 years. Tumours' characteristics were: cT1 in 75%, pN0 in 60%. Results: LRR rate was 38% at 10 years, contralateral breast cancer rate 12%. Age was the only prognostic factor for LRR. The relative risk of LRR increased by 7% for every decreasing year of age. The annual risk of local recurrence peaked between 2 and 3 years after the initial diagnosis and returned to the level of contra-lateral breast cancer at 10 years. The younger population had infiltrating carcinomas that were significantly more commonly ductal, less commonly lobular, and of higher grade - they received chemotherapy more often. Conclusion: Using conventional methods we could find no explanation as to why age remained the most important prognostic factor for breast cancer LRR. Known prognostic factors such as involved surgical margins seemed erased by adequate radiotherapy doses. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:272 / 280
页数:9
相关论文
共 56 条
[51]   Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer [J].
Veronesi, U ;
Cascinelli, N ;
Mariani, L ;
Greco, M ;
Saccozzi, R ;
Luini, A ;
Aguilar, M ;
Marubini, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1227-1232
[52]   Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J].
Vincent-Salomon, A ;
Rousseau, A ;
Jouve, M ;
Beuzeboc, P ;
Sigal-Zafrani, B ;
Fréneaux, P ;
Rosty, C ;
Nos, C ;
Campana, F ;
Klijanienko, J ;
Al Ghuzlan, A ;
Sastre-Garau, X .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) :1502-1508
[53]   Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials [J].
Voogd, AC ;
Nielsen, M ;
Peterse, JL ;
Blichert-Toft, M ;
Bartelink, H ;
Overgaard, M ;
van Tienhoven, G ;
Andersen, KW ;
Sylvester, RJ ;
van Dongen, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1688-1697
[54]   Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? [J].
Vrieling, C ;
Collette, L ;
Fourquet, A ;
Hoogenraad, WJ ;
Horiot, JC ;
Jager, JJ ;
Oei, SB ;
Peterse, HL ;
Pierart, M ;
Poortmans, PM ;
Struikmans, H ;
Van den Bogaert, W ;
Bartelink, H .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) :932-944
[55]   The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor [J].
Wazer, DE ;
Schmidt-Ullrich, RK ;
Ruthazer, R ;
DiPetrillo, T ;
Boyle, T ;
Kanski, J ;
Safaii, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04) :885-891
[56]   Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients [J].
Zellars, RC ;
Hilsenbeck, SG ;
Clark, GM ;
Allred, DC ;
Herman, TS ;
Chamness, GC ;
Elledge, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) :1906-1913